Truist raises CNX Resources stock price target on hedge book strength

Truist Securities raised its CNX Resources price target to $39 from $34 while keeping a Hold rating; shares were at $37.32. Truist expects Q4 production to be largely flat versus Q3 and fiscal 2027 production to match fiscal 2026, while citing the company’s hedge book and ongoing buybacks. CNX’s reported Q3 2026 adjusted EPS of $1.12 beat the $0.60 forecast and revenue of $580 million beat the $475.48 million estimate, but the stock declined amid cautious 2027 production expectations and weak Appalachian gas pricing.

Analysis

The key tension is cash-flow resilience versus limited volume growth. A substantial hedge book may reduce near-term downside and keep production online through weak Appalachian pricing, but it can also mute upside participation if spot prices strengthen; verify hedge volumes, prices, and expiry schedule before treating the earnings beat as repeatable. Flat production into FY27 shifts the equity case toward per-share value creation: buybacks can support metrics if shares are retired below intrinsic value, while an acquisition at returns below the buyback hurdle would dilute that discipline. The reported beat alone does not establish durable operating outperformance; separate realized commodity prices and hedge effects from costs, cash generation, and recurring production performance.

Near term, the raised target is close to the quoted share price, so it offers little fresh valuation impetus; the stock’s prior weakness despite strong results suggests the market is focused on forward gas pricing and stagnant output. Over 1–3 months, watch Appalachian basis/realizations, hedge coverage, and any FY27 guidance change. Over 6–18 months, sustained flat volumes make capital allocation and reserve replacement more important than headline EPS beats. M&A speculation is not a catalyst until CNX signals a transaction and demonstrates returns exceeding repurchases. The contrarian positive is that hedges and disciplined buybacks may make weak gas prices less damaging than a simple spot-price beta implies; the counterpoint is that this same protection does not create a growth rerating. Thesis weakens if guidance turns to declining volumes, cash generation disappoints after hedges, or buybacks fail to reduce diluted shares.

Key Decisions for Investors

• Stay neutral rather than chase the analyst-target increase at the quoted price. The near-term setup lacks a clear valuation catalyst, and the target is not a company valuation floor.
• For existing exposure, monitor quarterly free cash flow, hedge settlements, realized Appalachian pricing, and diluted share count. Treat the EPS beat as lower-quality until these measures confirm recurring improvement.
• Consider CNX only on weakness if hedge coverage and balance-sheet flexibility are verified; do not underwrite a takeover premium without a disclosed transaction and returns evidence.
• Relative-value watch: compare CNX with EQT Corporation and Antero Resources on production growth, basis exposure, hedge duration, and buyback yield. A material CNX guidance cut or adverse shift in Appalachian basis would falsify the resilience case and warrant reducing exposure.